[E-Daily Starin Choi Hee-jae Reporter] Actress Jeon Ji-hyun took home the Asian Star Award trophy at the 25th New York Asian Film Festival. Jeon Ji-hyun (Photo: Aqua Hsu) At the awards ceremony held during the gala event of the 25th New York Asian Film Festival on the 11th (local time), Jeon Ji-hyun received the Asian Star Award, considered the festival’s most prestigious honor. The Asian Star Award is presented to actors who have contributed to the development of Asian cinema and demonstrated outstanding achievements on the international stage; it is a meaningful and significant award that recognizes an actor’s accumulated body of work. The New York Asian Film Festival is a film festival that showcases a variety of genres from across Asia. Every year, leading actors and directors from the Asian film industry attend, drawing the attention of global film fans. The film “The Swarm,” starring Jeon Ji-hyun, was also selected as the opening night screening for the festival, which took place on the 10th. Jeon Ji-hyun attended the festival alongside “The Swarm” director Yeon Sang-ho, gracing the event with her presence. Jeon Ji-hyun has showcased her wide-ranging acting skills across various genres through films such as “October Love,” “My Sassy Girl,” “Meet My Girlfriend,” “The Thieves,” “Berlin,” and “Assassination.” This year, in the globally acclaimed film *The Group*, she delivered a compelling portrayal of Kwon Se-jeong—a biotechnology professor and leader of a group of survivors—who remains steadfast in her convictions even under extreme circumstances. “The Swarm” surpassed 5 million viewers last month, cementing its status as one of this year’s box office hits. Since its release, the film has broken records for the fastest time to reach 1 million, 2 million, 3 million, and 4 million viewers among this year’s releases, and continued its box office success by reaching the 5 million viewer milestone. Jeon Ji-hyun will return to the small screen next year in the JTBC drama “Human X Gumiho.”
Daelim Trading ( DaelimTrading(006570)), a company specializing in construction materials, is facing the threat of delisting due to chronic losses and deteriorating financial health. Observers note th…
The proprietary platform technologies of domestic biotech ventures have been selected one after another by Japan’s top-tier global manufacturers, which are known for their conservatism. The industry v…
PharmaResearch(214450)is staking its future on expanding into North America—the world’s largest beauty market—despite concerns over stagnant growth in its domestic market. At the same time, attention …